Morbid obesity is associated with increased resource utilization in coronary artery bypass grafting

Justin C Choi1, Faisal G Bakaeen, Lorraine D Cornwell

  • 1Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.

Insights

Morbidly obese patients undergoing coronary artery bypass grafting experience longer operating times and hospital stays, increasing resource utilization. While outcomes are good, the financial implications of these extended stays are significant for cardiac surgery.

Area of Science:

  • Cardiology
  • Bariatric Surgery
  • Health Economics

Background:

  • Morbidly obese patients undergoing cardiac surgery generally have positive outcomes.
  • However, the increased resource utilization associated with treating these patients remains largely unquantified.

Purpose of the Study:

  • To compare resource utilization between morbidly obese and non-morbidly obese patients undergoing coronary artery bypass grafting (CABG).
  • To determine if morbidly obese patients require longer operating room times, intensive care unit (ICU) stays, and hospital stays post-CABG.

Main Methods:

  • A retrospective review of 56 morbidly obese patients (BMI ≥40 kg/m²) who underwent CABG between 1999 and 2009.
  • Propensity-matched comparison with 168 non-morbidly obese patients (BMI 30.0 ± 2.8 kg/m²) at a 3:1 ratio.

Main Results:

  • No significant differences in preoperative characteristics (except creatinine) or complication/mortality rates between groups.
  • Morbidly obese patients experienced significantly longer operating times (449 vs. 420 minutes), ICU stays (5.2 vs. 3.3 days), and hospital stays (14.2 vs. 9.5 days).

Conclusions:

  • While successful outcomes are achievable, morbidly obese patients require substantially more resources during and after CABG.
  • The increased operating room and ICU utilization translates to significant financial implications for healthcare systems.
Abstract

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...